Krempa David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$504,317.63

Insider Activity of Krempa David

According to the SEC Form 4 filings, Krempa David, being in a position of

  1. Chief Business Officer at Eton Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 129166 shares for $5.09M,
    over all time since 2025-06-12, has bought 0 shares, and sold 163166 shares for $5.59M.

Biography of Krempa David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$5,086,0795100

Comparison of Insiders on Amount of Buys and Sells

2026-10-06SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
4,166
0.0153%
$55.07$229,406-6.44%
2026-08-24SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
25,000
0.0913%
$65.07$1.63M-14.12%
2026-05-27SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
19,679
0.0698%
$31.47$619,375+52.16%
2026-05-26SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
37,524
0.1332%
$31.49$1.18M+57.43%
2026-05-22SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
42,797
0.1601%
$33.39$1.43M+51.03%
2025-06-16SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
10,223
0.0396%
$14.73$150,585+22.94%
2025-06-13SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
6,800
0.0262%
$14.77$100,436+21.4%
2025-06-12SaleEton Pharmaceuticals, Inc.
ETON
Chief Business Officer
16,977
0.0651%
$14.92$253,297+19.37%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.